SULANTRIX LTD
Company number 13843002 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£189,589
Balance sheet as at 2025-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2022-01-12
- Employees
- 3 (2025 accounts · was 4 in 2024)
- Registered office
- 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ
- Postcode
- WC2H 9JQ
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-01-11
- Next due by
- 2027-01-25
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 1 resigned
Peter Michael WOODHALL
Director
David Hugh, Dr WILLIAMS
Director
Patrick Alexander, Dr EYERS
Director
Group structure 2 subsidiaries
-
SULANTRIX NO.2 LIMITED Dissolved
From persons-with-significant-control filings on the public register.
Contact details
- Website
- sulantrix.com
Sulantrix is a UK-based Biotech company focused on modulating members of the pseudoenzyme target class with small molecule drugs
Competitors London
-
3. NEWALR&D LTD
-
5. SENTCELL LTD
This company ranks 102 among research and experimental development on biotechnology in London.